INTRODUCTION {#S5}
============

Prader-Willi syndrome (PWS) affects about 1 in 15,000 to 1 in 30,000 individuals ^[@R1]--[@R2]^ and is characterized by typical facial features and major cognitive, behavioral, neurologic, endocrine, and psychiatric issues. PWS is an imprinting disorder caused by three main mechanisms, ultimately resulting in the complete absence of expression of the paternally imprinted genes in the 15q11.2-q13 region. These three genetic mechanisms leading to PWS are paternal deletion of this region (in about 70%), maternal uniparental disomy (in about 25%--30%), and imprinting center defect (in about 2--5%) ^[@R1]--[@R3]^. In the PWS region, the paternal copies of the genes are typically expressed while the maternal copies of these genes are silenced due to parent-of-origin-specific imprinting.

PWS is characterized by decreased fetal movement and neonatal hypotonia, decreased activity, and feeding difficulties leading to failure to thrive. Most individuals with PWS have mild intellectual disability, with a mean IQ of about 60--70, and most display a characteristic behavioral pattern, including temper tantrums, skin-picking, obsessive compulsive behaviors, stubbornness, and manipulative behavior, and attention deficit and hyperactivity symptoms may also occur, along with features suggestive of autism spectrum disorders ^[@R1],\ [@R4]--[@R5]^. Common characteristic facial features of individuals with PWS include almond-shaped and sometimes upslanting palpebral fissures, bitemporal narrowing, and strabismus ^[@R1],\ [@R4]^. Another characteristic feature of PWS in both sexes is hypogonadism, which manifests as genital hypoplasia (including cryptorchidism in males) and delayed or incomplete pubertal development ^[@R6]^.

The Center for Disease Control and Prevention (CDC) defines ART as fertility treatments involving the handling of both eggs and sperm, not just eggs or sperm. Such procedures include *in vitro* fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). According to the CDC and the National Center for Health Statistics, the 2006 U.S. frequency of ART-births, including only IVF, ICSI, GIFT, and ZIFT procedures, was less than 1.0% ^[@R7]^. Other methods such as intrauterine insemination (IUI) or fertility drugs to induce ovarian stimulation or ovulation can also be classified as ART; however, they are not included in the CDC definition.

Imprinting disorders and ART {#S6}
----------------------------

Recent reports have provided evidence for a relationship between imprinting disorders and assisted reproductive technologies. Angelman and Beckwith-Wiedemann syndromes are two disorders in which an imprinting defect accounts for a significant proportion of affected cases, with known increased risks for children born after ART ^[@R8]--[@R10]^. An association between Prader-Willi syndrome and ART has not been previously identified. It has been hypothesized that since maternal UPD and paternal deletions account for the majority of PWS cases, PWS may not be associated with ART ^[@R9]^. Nevertheless previous studies in Europe investigating this possible relationship have been conducted with small sample sizes and thus failed to ascertain a large number of individuals with PWS. To date, our study represents the largest one in the United States investigating the association between this imprinting disorder and ART.

MATERIALS AND METHODS {#S7}
=====================

This study followed unique data collection protocols for three distinct PWS populations including the following:

The Prader-Willi Syndrome Association (USA) \[PWSA (USA)\] {#S8}
----------------------------------------------------------

A survey about prenatal, medical, and family histories was created and posted on the organization's website in 2004. Families with an individual with Prader-Willi syndrome who were members of PWSA (USA) were invited to participate in the survey and 1,600 such families responded to Questionnaire 1 regarding the use of assisted reproductive techniques for conception of the individuals with PWS. Those families who underwent ART were invited to complete a secondary survey, referred to as Questionnaire 2 for our study. Questionnaire 2 included repeat questions from the first PWSA (USA) survey to confirm initial responses. These repeat questions were answered the same in both questionnaires. Questionnaire 2 requested the following information about the individual with PWS: Maternal and paternal ages at participant's birthGenetic subtype of PWSType of assisted reproductive technology utilizedLocation where the ART procedure was doneNumber, ages, and genders of other siblingsParents' past history of miscarriagesWhether or not the participant was a co-twin. For this study, data collected from Questionnaire 1 included age, birth year, and gender. Data were also collected on whether or not an individual with PWS was born following ART.

The Rare Diseases Clinical Research Network (RDCRN) {#S9}
---------------------------------------------------

Data on individuals with PWS were collected through the use of the NIH sponsored Rare Diseases Clinical Research Network (RDCRN) Natural History PWS and Morbid Obesity Clinical Protocol (IRB protocol 2007--5605). This RDCRN study is composed of four centers, including the University of Florida Health Science Center in Gainesville, Florida; University of Kansas Medical Center in Kansas City, Kansas; Vanderbilt University Medical Center in Nashville, Tennessee, and Baylor College of Medicine in Houston, Texas.

At the time of the study, the RDCRN database contained a total of 108 participants enrolled at the four centers. Demographic, medical, education, and familial surveys were completed for each individual in the database. In addition, the following data were collected from the Data Technology Coordinating Center (DTCC) on behalf of the RDCRN: age, birth year, gender, PWS genetic subtype, maternal age at birth, and paternal age at birth.

University of California, Irvine Medical Center (UCIMC) Clinical Service {#S10}
------------------------------------------------------------------------

Information about individuals with Prader-Willi syndrome who were seen by the UCIMC Division of Genetics and Metabolism is maintained in the local database. Medical records for each individual were reviewed to confirm the diagnosis, determine the genetic PWS subtype and to investigate whether conception included the use of assisted reproductive techniques. Other data collected from the medical records were the age, birth year, gender, maternal age at birth, and paternal age at birth.

In the United States, all clinics that perform ART procedures must report their pregnancy success rate data to the Centers for Disease Control and Prevention (CDC) under the Fertility Clinic Success Rate and Certification Act of 1992. The Society for Assisted Reproductive Technology maintains a database of ART procedures performed in these clinics each year and makes these data available to the CDC. The CDC publishes these results and estimates that the database accounts for about 95% of ART procedures performed in the U.S. each year. These data were used to determine the incidence of ART-births in the U.S. to compare to the incidence of ART-births in the PWS study population during similar birth years ^[@R7]^. Only procedures defined by the CDC, including IVF, ICSI, GIFT, and ZIFT, were considered ART.

This study involved review of medical records and questionnaire responses from participants at the three distinct clinical sites to investigate the proportion of ART-births in the PWS study population and the proportion of the two genetic mechanisms causing PWS, maternal UPD and imprinting defects, in the ART-conceived and naturally-conceived groups. The sample sizes for the RDCRN and UCIMC in particular were limited.

Statistical analysis was performed using SPSS for Windows software (version 15.0, SPSS). To compare the twin proportion or ART-birth proportion in the PWS study population to that in the general U.S. population, Pearson chi-square test one-sample goodness-of-fit was used; *p*\< 0.05 was considered as statistically significant. Comparisons among the various proportions of genetic subtypes were performed by testing the marginal frequencies of the contingency tables for these three independent clinic sites.

RESULTS {#S11}
=======

Of the total 1,898 individuals with PWS surveyed for this study, 20 were conceived after ART procedures defined by the CDC (18 from the PWSA (USA) and one each from the RDCRN and UCIMC). The mean age at the time of this study for the individuals with PWS from PWSA (USA), RDCRN, and UCIMC was 19.0, 10.1, and 15.0 years, respectively. The range of birth years for those individuals with PWS born after ART was from 1994 to 2006. The combined proportion was 1.1% (20/1,884; 95% confidence interval (CI) 0.6%--1.6%). The number and percentage of those conceived after ART are displayed in [Table 1](#T1){ref-type="table"}.

The CDC has been publishing the estimated U.S. rate of individuals born after IVF (*in vitro* fertilization), ICSI (intracytoplasmic sperm injection), GIFT (gamete intrafallopian transfer), and ZIFT (zygote intrafallopian transfer) procedures annually since 1995. No other ART procedures were included in this estimation. In order to compare accurately the proportion of ART-births in the PWS study population with that in the general U.S. population, only those conceived after IVF, ICSI, GIFT, and ZIFT procedures were included as ART-births for this comparison ([Table 2](#T2){ref-type="table"}). Twenty participants were conceived after CDC-recognized ART procedures (IVF, ICSI, and ZIFT; none were reported as conceived following GIFT). Twenty participants conceived following IUI or ovarian stimulation, both non-CDC ART procedures, were included in the naturally-conceived group.

The proportion of ART-births in the PWS study population (including only the twenty conceived after IVF, ICSI, and ZIFT procedures) was 1.1% (20/1,884; 95% CI 0.6%--1.6%). The ART status for ten RDCRN participants was unknown, so these individuals were removed from the study. Four PWSA (USA) participants were also removed from the study because they did not provide the specific type of ART utilized. These omitted data did not significantly change the study's overall proportion of ART-births of 1.1%. The mean frequency of U.S. ART-births between the twelve years in which the study participants were born was calculated to be 1.0%. The proportion of ART-births in the PWS study population and the general U.S. population were calculated to be similar by Pearson chi-square test (*p*=0.788), indicating that there was no significant increase in ART-births in the PWS study population.

The mean parental ages in the ART-conceived group may provide an explanation for the increased proportion of maternal UPD/imprinting defects seen in the ART-conceived group. However, data on parental ages were only available for a small number of naturally-conceived participants and an even smaller number of ART-conceived participants from each site. Statistical comparison on mean parental ages for the ART- and naturally-conceived groups from the RDCRN and UCIMC sites could not be performed separately because of the small sample size and limited power. For example, there were only two participants (one ART-conceived and one naturally-conceived) from the RDCRN with parental ages reported. There was also a strong imbalance in the number of participants with parental ages in the UCIMC ART and non-ART groups: maternal ages were available for one ART-conceived patient and 49 naturally-conceived patients while paternal ages were available for one ART-conceived patient and 48 naturally-conceived patients. Therefore, statistical comparison on mean parental ages for the ART- and naturally-conceived groups was restricted to the PWSA (USA) site only.

From the PWSA (USA) site, 18 participants reported maternal ages (10 ART-conceived and 8 naturally-conceived), and 16 reported paternal ages (9 ART-conceived and 7 naturally-conceived). While PWSA (USA) also had a small sample size, the number of participants with parental ages was fairly consistent between the ART and non-ART groups. The mean parental ages at birth were greater in the ART-conceived group (36.3 and 39.7 years, respectively, for mothers and fathers) in comparison to the naturally-conceived group (31.5 and 31.6 years, respectively). These differences in ART and non-ART parental ages were statistically significant (*p*=0.049 and *p*=0.020 for mothers and fathers, respectively).

Frequency of the genetic subtypes of PWS {#S12}
----------------------------------------

This study hypothesized a higher proportion of maternal UPD and imprinting center defects in ART-conceived individuals compared to those naturally-conceived. [Table 3](#T3){ref-type="table"} reports the data for all participants for whom the genetic subtype was available (N=1,250), by clinic site. Those with maternal UPD and imprinting defects were combined since the two genetic subtypes were not distinguished for some participants. For example, 333 and 37 participants from PWSA (USA) had maternal UPD and imprinting defects, respectively. The RDCRN data included 32 with maternal UPD, 4 with imprinting defects, and 3 with either maternal UPD or imprinting defects. The UCIMC data included 9 with maternal UPD, and 13 with either maternal UPD or imprinting defects. These data were combined across the three sites.

These data were compared to the expected proportion of the genetic subtypes in the general PWS population. The observed proportion of participants with a deletion was 65.5% (819/1,250; 95% CI 62.9% to 68.1%) which is consistent with the expected range of 65% to 75%. The observed proportion with maternal UPD and imprinting defects was 34.5% (431/1,250; 95% CI 31.9% to 37.1%), consistent with the expected range of 25% to 35%.

The two genetic subgroups were found in different proportions in the ART-conceived group compared with those naturally-conceived (*p*=0.02). In the ART-conceived group, the proportion with maternal UPD or imprinting defects was 55.6% (10/18), while among those naturally-conceived the proportion was 34.2% (421/1,232). Compared to naturally-conceived participants, those who were ART-conceived were more likely to have UPD and imprinting defects than deletions.

Frequency of twins {#S13}
------------------

The number of participants who were co-twins was evaluated to determine the frequency of twinning in the PWS population with or without the use of ART procedures. [Table 4](#T4){ref-type="table"} displays the number of co-twins from each site; only one twin of each twin pair was affected with PWS. There was no significant difference in the proportion of twins from each site; therefore, these data were combined to calculate the total twin frequency for this study. The total proportion of twins of 2.4% (45/1,898; 95% CI 1.7% to 3.1%) was statistically significantly different (*p*=0.007) from the U.S. twin frequency of 1.6% ^[@R7]^. Since previous studies reported an increased rate of twinning (both monozygotic and dizygotic) after the use of assisted reproduction ^[@R11]--[@R13]^, eleven (24.4%) of these PWS co-twins, all fraternal, who were conceived after ART procedures, were excluded from the overall twin frequency in the PWS study population. For all naturally-conceived PWS patients, the modified twin frequency of 1.8% (34/1,844; 95% CI 1.2% to 2.4%) was obtained, which was not significantly different from the U.S. population twin frequency (*p*=0.404). Thirty-one percent (14/45) of the total PWS co-twins were reported as identical twins, and 69% (31/45) were reported as fraternal twins.

DISCUSSION {#S14}
==========

This study demonstrated that the proportion of ART-births in the PWS study population was not significantly increased above that in the general U.S. population. Results from this study were consistent with previous research suggesting that ART is not associated with an increased risk of PWS.

Multiple studies have concluded that the effects of ART procedures may be restricted to imprinting disorders, such as AS and BWS, in which methylation patterns result in the loss of expression of the maternal allele, or in which an imprinting defect accounts for a significant proportion of affected cases ^[@R14]--[@R15]^. An imprinting center defect in an ART-conceived individual with PWS has not been previously reported in the literature ^[@R9],\ [@R16]^; however, two ART-conceived individuals confirmed with imprinting center defects were found in our study.

Although this study did not find a significantly increased proportion of ART-births in the PWS study population using the CDC definition (including IVF, ICSI, and ZIFT), the sample also includes individuals who were conceived using other ART methods, such as ovulation-inducing drugs and intrauterine insemination. The use of these procedures should not be ignored in this PWS population since they may contribute to an increased frequency of imprinting disorders following all ART techniques ^[@R17]^. Therefore, it is imperative to note all types of assisted reproductive techniques utilized in order to further investigate their effects on imprinting mechanisms and association with PWS.

These results support a significant difference between the ART-conceived and naturally-conceived groups with respect to the proportion of maternal UPD and imprinting center defects. However, overall there was no significant association detected between ART and PWS. One limitation to this comparison was the small sample size; data on the PWS genetic subtypes were available for only 18 of the 20 participants in the CDC-defined ART group.

The mean parental ages in the ART-conceived group may provide an explanation for the increased proportion of maternal UPD/imprinting defects seen in the ART-conceived group. Statistical comparisons were performed for the PWSA (USA) group only, and the mean maternal age at birth was greater in the ART-conceived group (36.3 years) than in the naturally-conceived group (31.5 years) (*p*=0.049). The mean paternal age at birth was also greater in the ART-conceived group (39.7 years) than in the non-ART group (31.6 years) (*p*=0.020). This statistical comparison was limited by the small sample sizes and low power. Parental data from the RDCRN and UCIMC groups could not be compared separately within each group nor could it be combined with the UCIMC parental data.

However, these results are consistent with previous studies looking at the maternal age effects on the increased incidence of maternal UPD in individuals with PWS. Matsubara *et al.* (2011) studied maternal age effect on the development of Prader-Willi syndrome in 117 Japanese patients with PWS. Their results implied that the advanced maternal age at childbirth is a predisposing factor for the development of maternal 15 UPD because of increased meiosis 1 errors ^[@R18]^.

Also, Whittington *et al.* (2007) reported a greater proportion (50%) of maternal UPD in 34 individuals less than five years of age with PWS. Whittington *et al.* (2007) ^[@R19]--[@R20]^ proposed that increased maternal age at the individual's birth would most likely explain the changing proportions of UPD and deletions in this generation of individuals with PWS. The possible differences in parental ages in the ART- and naturally-conceived individuals with PWS may also suggest an explanation for the observed ART-birth proportion of 2.3% (44/1,888) when all types of assisted reproduction (not just IVF, ICSI, GIFT, and ZIFT) were considered. The individuals in the ART-conceived group may be more likely to have older mothers and fathers. These older parents may have experienced infertility issues due to advanced parental ages and pursued ART procedures in order to conceive a child. As previously mentioned, maternal UPD is associated with increasing maternal age, so the ART-conceived participants may be affected with PWS due to mechanisms causing UPD and not due to the ART procedures themselves.

Another possible explanation for the increased proportion of maternal UPD and imprinting defects found in the ART-conceived PWS population may be a response bias, and more individuals with maternal UPD may have been included in this study. For example, families with a child with PWS with maternal UPD may be more involved in the PWS community. Individuals with PWS due to maternal UPD are less severely affected; they have higher verbal IQ and milder physical features than those with deletions ^[@R1],\ [@R5],\ [@R21]^. The milder PWS phenotype in younger individuals with UPD may allow families to be more involved in studies and to participate in questionnaires. If this is the case, the data may be biased with fewer individuals with a paternal deletion included in this study.

Response bias could have also occurred across sites since each study group utilized different methods to collect data from patients. The PWSA (USA) used voluntary and anonymous questionnaires, with the initial survey posted online. The RDCRN collected data strictly on a research basis through its network while data from the UCIMC patients were obtained from a clinical perspective during genetics visits. Completing an online questionnaire may have been more convenient for some families instead of scheduling face-to-face genetics appointments. In any case, reporting bias could not be ruled out. Lastly, the stigma associated with infertility could have attributed to the less than honest reporting of ART for some families; however, this particular response bias could have been applied to all three sites.

While this study agrees with previous reports stating no association between ART and PWS ^[@R22]^, further investigation with a larger sample size and higher power is needed in order to detect a possible association. Furthermore, it still remains to be determined whether other factors besides IVF and ICSI procedures are affecting the increased incidence of imprinting disorders ^[@R23]^. Previous studies have reported that imprinting defects may be caused by either the subfertility of the couple or superovulation and hormone treatment and not due to the ART procedure itself. For instance, Ludwig *et al.* (2005) ^[@R17]^ reported an increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples and suggested that superovulation, rather than ICSI, may further increase the risk of an imprinting defect in the child. Sutcliffe *et al.* (2006) ^[@R9]^ also discovered similar results. In addition, some of the imprinting disturbances suggested to be associated with ART may already be present in the gametes of infertile men being used for ICSI ^[@R24]^.

Most evidence related to ART suggests altered methylation status of the maternal allele, or the female gamete imprint. This maternal imprint is erased and re-established in female gametes prior to ovulation at the 1N stage, which occurs much later in comparison to the establishment of the paternal imprint at the 2N stage in spermatogenesis ^[@R25]^. The critical time difference in gametogenesis for the maintenance of parental imprints supports the hypothesis that ART can affect methylation of maternal imprints rather than paternal imprints. This also supports the finding that PWS is not increased after ART as the molecular cause of this condition is the loss of the paternal allele, which is not methylated. Future research investigating these hypotheses must be done in order to elucidate true causes for the increased incidence of imprinting disorders in children born after ART procedures.

This study also demonstrated no association between twinning and PWS when ART-conceived pregnancies were excluded.

CONCLUSIONS {#S15}
===========

This study did not find an increased risk of ART-conceived pregnancies among individuals with PWS but did find a significantly increased proportion of maternal UPD and imprinting defects in the ART-conceived PWS study population. Although this finding cannot provide a definite link between ART and increased frequencies of maternal UPD and imprinting defects, it is anticipated that the data collected will provide a foundation for future investigations. Results from long-term studies are also necessary to properly counsel couples considering these assisted reproductive technologies and may possibly suggest the need to offer genetic screening, evaluation, and monitoring of ART-conceived children.

Although the absolute risk of PWS, and other imprinting diseases, may be small with ART, further investigations, including large, long-term prospective studies, are recommended to assess the health and development of ART-conceived children.
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###### 

Number and percentage of ART-conceived participants with PWS from each studied group.

                        PWSA (USA)   RDCRN     UCIMC   TOTAL                            
  --------------------- ------------ --------- ------- --------- ---- --------- ------- ---------
  ART-Conceived         18           (1.0)     1       (1.0)     1    (2.0)     20      (1.1)
  Naturally-Conceived   1,718        (99.0)    97      (99.0)    49   (98.0)    1,864   (98.9)
  Total                 1,736        (100.0)   98      (100.0)   50   (100.0)   1,884   (100.0)
  Unknown ART Use       4                      10                0              14      

**key:** chi-square=0.072 1 df *p*=0.788

###### 

Number and percentage of ART-conceived participants with PWS from each studied group with each ART procedure.

  Type of ART          PWSA (USA)   RDCRN     UCIMC   Total                        
  -------------------- ------------ --------- ------- --------- --- --------- ---- ---------
  **IVF Variations**                                                               
    IVF only           9            (50.0)    0       \(0\)     1   \(100\)   10   (50.0)
    IVF/ICSI           3            (16.7)    0       \(0\)     0   \(0\)     3    (15.0)
    IVF/Donor Egg      5            (27.8)    1       \(100\)   0   \(0\)     6    (30.0)
    ZIFT               1            (5.5)     0       \(0\)     0   \(0\)     1    (5.0)
  **Total**            18           \(100\)   1       \(100\)   1   \(100\)   20   \(100\)

**key:** ivf= *in vitro* fertilization, icsi= intracytoplasmic sperm injection, zift= zygote intrafallopian transfer

###### 

Number and percentage of naturally-conceived and ART-conceived participants with PWS from each site with a deletion or maternal UPD/ imprinting defect.

  -------------------------------------------------------------------------------------------------
  Genetic\      PWSA (USA)\   RDCRN\    UCIMC\    TOTAL\                                  
  Subtype\      N (%)         N (%)     N (%)     N (%)                                   
  of PWS                                                                                  
  ------------- ------------- --------- --------- --------- --------- --------- --------- ---------
  Deletion      726\          7\        62\       1\        23\       0\        811\      8\
                (66.8)        (43.7)    (61.4)    (100.0)   (52.3)    (0)       (65.8)    (44.4)

  Maternal\     361\          9\        39\       0\        21\       1\        421\      10\
  UPD/\         (33.2)        (56.3)    (38.6)    (0)       (47.7)    (100.0)   (34.2)    (55.6)
  Imprinting\                                                                             
  Defect                                                                                  

  Total         1,087\        16\       101\      1\        44\       1\        1,232\    18\
                (100.0)       (100.0)   (100.0)   (100.0)   (100.0)   (100.0)   (100.0)   (100.0)
  -------------------------------------------------------------------------------------------------

###### 

Number and percentage of participants with PWS who were co-twins.

  ------------------------------------------------------------------------------------------
  Patients     PWSA (USA)\     RDCRN\        UCIMC\       TOTAL\          Expected U.S.\
               N (%)           N (%)         N (%)        N (%)           Twin Frequency\
                                                                          (%)\
                                                                          (Hoekstra, Zhao\
                                                                          *et al*. 2008)
  ------------ --------------- ------------- ------------ --------------- ------------------
  Twins        42 (2.4)        1 (0.1)       2 (4.0)      45 (2.4)        (1.6)

  Singletons   1,698 (97.6)    107 (99.9)    48 (96.0)    1,853 (97.6)    (98.4)

  Total        1,740 (100.0)   108 (100.0)   50 (100.0)   1,898 (100.0)   (100.0)
  ------------------------------------------------------------------------------------------

**key:** chi-square=7.162 1 df *p*=0.007
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